The US Food and Drug Administration (FDA) has approved sarilumab (Kevzara) for the treatment of polyarticular juvenile ...
A 35-year-old man was admitted to the intensive care unit (ICU) with a progressive skin and soft tissue infection of the arm ...
The US Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo (elafibranor; Ipsen) for treatment of ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on ...
Kratom, used like an opioid, widely available online and elsewhere, and increasingly popular, can cause hyperpigmentation ...
In children with Marfan syndrome who undergo lens removal, the risk for retinal detachment increases 16-fold when capsular ...
The US Food and Drug Administration has approved a supplemental new drug application for tirbanibulin topical ointment, ...
BOSTON — Men who stop using performance-enhancing anabolic-androgenic steroids (AAS) experience significant depression, ...
A new report defines the infection-associated chronic condition as lasting at least 3 months, with single or multiple symptoms and without need for confirmatory tests.
MILAN — Seladelpar, an investigational selective peroxisome proliferator-activated receptor delta agonist, achieves both ...
HOUSTON, Texas — Obstructive sleep apnea (OSA) not only affects the patient's health but also disrupts their partner's sleep, ...
Patients with heart failure and preserved ejection fraction have symptomatic and functional improvements with semaglutide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback